Stem Cell Sciences Shareholders Support Sale to StemCells
NEW YORK (GenomeWeb News) – Shareholders of UK-based Stem Cell Sciences have voted in favor of selling the firm’s assets to Stem Cell Sciences. The vote is the most recent step in SCS’ plans to sell off its assets and delist from the AIM and Australian Securities Exchange.
[Read the full article here]Related News:
StemCells to Acquire Stem Cell Sciences for $4.8M (GenomeWeb News)
StemCells, Inc. To Acquire Cell-Based Drug Discovery Platforms And Related Businesses Of Stem Cell Sciences plc
StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc (Centre Daily Times)